This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

Knowledge, expertise, and familiarity with the various drugs used to treat anxiety disorders are fundamental for proper treatment and patient safety. It is necessary that pharmacists properly monitor for commonly serious adverse effects of medications. They can also play a vital role in education and help provide counseling tips and recommendations for selecting an optimal medication based on patient-specific factors.

After taking this course, you should be able to:

  • Review various drug classes used to treat anxiety disorders
  • Compare and contrast pharmacotherapy options for the treatment of anxiety disorders with regards to their safety, efficacy, and place in therapy
  • Describe the pharmacistÂ’s role in the management of anxiety disorders
  • Recognize various drug classes and pharmacotherapy options for treating anxiety disorders regarding their safety, efficacy, and place in therapy.
  • Define the pharmacist’s role in the management of anxiety disorders.
  • Identify the various types of anxiety disorders and their common characteristics

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/24

Course Originally Released On: 02/01/22

Course Authors

4.3 Average

Course Reviews

3840 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.